To the full analysis
Buyback calculator for HUTCHMED (China)
HUTCHMED (China) stock: key metrics
HCMHUTCHMED (China) had an operating margin of −10% and a return on invested capital (ROIC) of −4% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 57.7% | −10.7% | −19.0% |
| 2007 | 57.5% | −14.9% | no data |
| 2008 | 58.5% | −16.4% | −20.4% |
| 2009 | 59.8% | −4.2% | −7.9% |
| 2010 | 59.4% | −1.6% | −5.1% |
| 2011 | 55.2% | 2.5% | no data |
| 2012 | no data | no data | no data |
| 2013 | 51.7% | −2.3% | no data |
| 2014 | 32.6% | −20.9% | −37.6% |
| 2015 | 37.8% | −5.5% | 4.5% |
| 2016 | 27.7% | −21.6% | 5.4% |
| 2017 | 27.1% | −22.1% | −11.1% |
| 2018 | 32.8% | −43.3% | −34.9% |
| 2019 | 21.8% | −74.6% | −51.7% |
| 2020 | 17.3% | −87.0% | −55.2% |
| 2021 | 91.9% | −100.3% | −54.7% |
| 2022 | 27.0% | −168.6% | −84.6% |
| 2023 | 54.1% | 2.2% | 12.0% |
| 2024 | 44.8% | −6.9% | 6.0% |
| 2025 | 38.7% | −10.0% | 83.3% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −9.3% | −9.1% | −7.2% |
| 2007 | no data | −15.8% | no data |
| 2008 | −23.6% | −21.5% | −15.1% |
| 2009 | −13.3% | −7.6% | −6.8% |
| 2010 | −11.5% | −3.9% | −4.3% |
| 2011 | no data | 4.1% | no data |
| 2012 | no data | −20.2% | no data |
| 2013 | no data | −0.8% | no data |
| 2014 | −83.8% | −12.8% | −15.6% |
| 2015 | 9.6% | −7.0% | 3.5% |
| 2016 | 6.3% | −24.7% | 3.4% |
| 2017 | −5.8% | −26.6% | −4.5% |
| 2018 | −19.2% | −49.1% | −14.1% |
| 2019 | −36.8% | −90.0% | −22.8% |
| 2020 | −26.0% | −34.1% | −17.4% |
| 2021 | −19.7% | −34.1% | −14.2% |
| 2022 | −59.1% | −64.3% | −35.1% |
| 2023 | 13.8% | 2.2% | 7.9% |
| 2024 | 5.0% | −4.0% | 3.0% |
| 2025 | 37.0% | −4.0% | 26.1% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 24 Apr 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.